Biodesix (BDSX) faces potential 26.7% upside implied by the consensus price target, though the article notes this metric is not a strong predictor. The main near-term catalyst cited is an upward trend in earnings estimate revisions, which could support additional stock upside.
Biodesix (BDSX) faces potential 26.7% upside implied by the consensus price target, though the article notes this metric is not a strong predictor. The main near-term catalyst cited is an upward trend in earnings estimate revisions, which could support additional stock upside.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.12
Ticker Sentiment
